T cell receptor alpha variable 8-7 (pseudogene) (TRAV8-7)

T cell receptor alpha variable 8-7 (TRAV8-7) is classified as a pseudogene within the human locus encoding T cell receptor alpha (TRA) variable regions[1]. The T cell receptor (TCR) is a complex essential for T cell recognition of antigenic peptides bound to major histocompatibility complex (MHC) molecules, a process fundamental to the adaptive immune response[3][1]. However, the TRAV8-7 gene segment itself is annotated as a pseudogene and does not produce a functional protein product[1]. As such, TRAV8-7 does not contribute directly to canonical TCR structure or T cell function, and it is not considered a therapeutic target or a functional biomarker. Key contextual details: - The T cell receptor alpha gene locus contains many variable (V) gene segments, some of which are functional, and others, like TRAV8-7, are pseudogenes incapable of encoding a protein, playing no direct biological or therapeutic role[1]. - The broader TCR complex, composed of variable alpha and beta chains, is a central immunological receptor responsible for antigen recognition, signaling, and activation of T cells, but TRAV8-7 (as a pseudogene) is not an active participant in these processes[1][2][3][5]. - No drugs or therapeutics are known or expected to interact with this pseudogene, nor are there safety concerns associated with it. Summary of correctness: The queried target, "T cell receptor alpha variable 8-7" (TRAV8-7), is correctly named and identified as a pseudogene, not a functional receptor or therapeutic target[1]. Therefore, it does not fit typical drug discovery or biomarker paradigms.

Other names

TRAV8-7TCRA-V8S7AV8S7T cell receptor alpha variable gene segment 8-7